National Supporters

Abbott Diabetes Care is a supporter of Time In Range, the American Diabetes Association’s nationwide effort to encourage measuring and monitoring of blood glucose levels ‘beyond A1C’ to improve outcomes and better manage diabetes. In addition, Abbott is a Founding Sponsor of Health Equity Now, a national platform to ensure that all people living with diabetes, and the millions of underserved Americans who are at greatest risk for diabetes, have access to health resources that are too often unavailable to them. Abbott also supports the American Diabetes Association’s Amputation Prevention Campaign to help disrupt the curve of amputations among low-income and minority individuals with diabetes.

View website
 

Dexcom, Inc., headquartered in San Diego, CA, is dedicated to developing innovative glucose sensing technology and products to help patients and healthcare providers better manage diabetes. The Dexcom G6 Continuous Glucose Monitoring (CGM) System does not require fingersticks for calibration or diabetes treatment decisions* and features simple, one-touch sensor insertion.2 The System provides exceptional accuracy with an overall MARD of 9.0%†2 and features an Urgent Low Soon alert that can warn users 20 minutes in advance of severe hypoglycemia (55 mg/dL). Dexcom is the only provider of CGM systems indicated for children ages 2 years and older. 

Visit Website

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 
†MARD is a statistical measure of accuracy; the lower the number, the better.

Genentech is an Anchor Partner of the American Diabetes Association Health Equity Now Initiative. The initiative will bring together local partners and grassroots organizations to increase awareness about diabetic eye health in communities with the highest disease burden. Our shared goal is to empower people with diabetes by identifying and removing barriers to eye care that can save their vision.

• Racial and ethnic minorities are two to three times more likely to develop significant visual complications such as diabetic macular edema than white patients and black men are twice as likely to die from diabetes compared to their White counterparts.

With the ADA we are increasing awareness about diabetes and eye health, and addressing health disparities in communities with the highest disease disparity.

View website

Eli Lilly and Company has provided funding for scholarships for families needing economic assistance to send their children to diabetes camp for more than 20 years. They were a founding sponsor of Pathway to Stop Diabetes, a research program designed to find the next generation of diabetes researchers and serve as a national sponsor of Project Power for adults.

View website

Medtronic Diabetes is a sponsor of Health Equity Now, a national platform to ensure that all people living with diabetes, and the millions of underserved Americans who are at greatest risk for diabetes, have access to health resources that are too often unavailable to them. Medtronic also supports the American Diabetes Association’s Amputation Prevention Campaign to help disrupt the curve of amputations among low-income and minority individuals with diabetes.

View website

Novo Nordisk is a sponsor of the American Diabetes Association’s (ADA) Imagine Camps. ADA Imagine Camp is designed to facilitate a free, at-home virtual experience, providing opportunities for children with diabetes to connect as never before! Novo Nordisk also continues to support Scientific Sessions, the world's largest meeting on diabetes.

Novo has also helped to support the launch and execution of the diabetes cardiovascular initiative Know Diabetes by Heart™, which is a collaboration between the American Diabetes Association and the American Heart Association.

View website

Xeris is a National Supporter of the American Diabetes Association. The 2024 Standards of Care by the American Diabetes Association emphasizes the importance of prescribing glucagon for individuals with diabetes who are at a heightened risk for level 2 and 3 hypoglycemia patients on insulin and sulfonylureas and states that ready-to-use glucagon formulations may be beneficial in view of safety, efficacy, and ease of use. Xeris takes pride in supporting the ADA's efforts to ensure that not only people with diabetes, but also those who provide support are aware of the availability of ready-to-use glucagon options.

View the website

Amgen has provided funding for the ADA’s Strategic Alliance Council, the Interactive Obesity Experience at the 2025 ADA Scientific Sessions, and they support our advocacy work around patient access to obesity medications to increase access to comprehensive obesity treatment and services across the continuum of care, including pharmacological medications.

View website

Bayer Healthcare is a national sponsor of the American Diabetes Association’s Know Diabetes By Heart campaign alongside the American Heart Association. This initiative’s purpose is to reduce cardiovascular death (CVD), heart attack, heart failure and stroke in people living with type 2 diabetes (T2D).

View website

DaVita is a health care community focused on transforming care delivery to improve quality of life for patients living with chronic kidney disease.  As one of the largest providers of kidney care services in the U.S., DaVita is a leader in clinical quality and innovation, particularly for those living with chronic kidney disease. Both DaVita and the American Diabetes Association believe in the importance of healthy living for those with diabetes, prediabetes, chronic kidney disease and their families.

View website

Sanofi supports phase 3 of ADA’s Therapeutic Inertia program. The main goal of phase 3 is to promote the measurable adoption of evidence-based practices, strategies, programs and tools that address key barriers associated with therapeutic inertia in diabetes care, leading to improved, timely treatment modification and improved overall glycemic control in adult patients with type 2 diabetes. Sanofi also supported the American Diabetes Association’s 100 Years of Insulin, a year-long campaign that focused on awareness, education and promoting activities that build community.

View website

As the largest and only national not-for-profit vision benefits company, VSP™ Vision Care provides affordable access to high quality eye care and eyewear for more than 85 million members through a network of more than 41,000 doctors. A leader in health-focused vision care, VSP, is a national sponsor of American Diabetes Association and the Focus on Diabetes® eye health initiative and is committed to raising awareness of the crucial role optometrists play in preserving the sight of the 133 million Americans living with diabetes and prediabetes.

View website